CIK 0001796280 · Non-accelerated filer
Oric Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ORIC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471787157
- Phone
- (650) 388-5600
- Business address
- 240 E. GRAND AVE., 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,519,090
- in 5 filings, $1.5M under 10b5-1 plans
Net −$1,519,090. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 51 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-13 | Chacko Jacob President and CEO | Sale | −2,801 | $25.02 | $70K | 10,808 |
| 2021-09-10 | Heyman Richard A. Director | Sale | −479 | $25.10 | $12K | 218,261 |
| 2021-09-10 | Chacko Jacob President and CEO | Sale | −2,942 | $25.08 | $74K | 13,609 |
| 2021-09-08 | Chacko Jacob President and CEO | Sale | −200 | $25.04 | $5K | 16,551 |
| 2021-09-07 | Heyman Richard A. Director | Sale | −1,086 | $25.11 | $27K | 218,740 |
| 2021-09-07 | Chacko Jacob President and CEO | Sale | −5,981 | $25.11 | $150K | 16,751 |
| 2021-08-13 | Hoerter Steven L. Director | Grant or award · Stock Option (right to buy) | +33,250 | 33,250 | ||
| 2021-06-16 | Svennilson Peter Director | Grant or award · Stock Option (right to buy) | +16,625 | 16,625 |
Page 12 of 12 · 228 trades